Impact of drug resistance on the tuberculosis treatment outcome
Journal Title: Актуальна інфектологія - Year 2017, Vol 5, Issue 2
Abstract
Background. The standard treatment of a new case of multidrug-resistant tuberculosis (MDR-TB) according to WHO recommendations in the Republic of Moldova is performed since 2005 showing a low treatment succes. Actually the treatment success rate increased due to excluding of MDR-TB patients from the general cohort. The major rate of patients with low outcome is represented by the failed and lost to follow-up cases. The purpose of the study was to assess the impact of multidrug-resiatnce and MDR-TB on the tuberculosis treatment outcome. Materials and methods. A retrospective selective, descriptive study targeting social, demographic, economic and epidemiological peculiarities, case-management, diagnostic radiological aspects and microbiological characteristics of 187 patients with pulmonary tuberculosis registered during 2013–2015 distributed in two groups: 1st group (61 patients) with established multidrug-resistant strains using conventional cultural methods and the 2nd group (126 patients) with MDR-TB. Results. Multidrug-resistance was established more frequently in new cases and MDR-TB in two thirds of retreated patients. No difference was identified in gender and age distribution, social, economical, educational characteristics; case-management assessment identified a similar proportion of patients revealed by general practitioners and specialists, with low rate of screened high risk groups. All patients from the multidrug-resistant group began the standard treatment for drug-responsiveness tuberculosis before drug susceptibility testing and one third of MDR-TB group was treated from the onset with the DOTS-Plus regimen. Highest success rate was identified in the new-case subgroups of both groups and higher rate of died patients was determined in the retreated subgroups. Such a low rate of patients aggrevates the resistance. Conclusions. Early diagnosis, drug responsiveness testing and raising awareness among about treatment compliance will improve disease outcome.
Authors and Affiliations
E. Lesnic, A. Niguleanu, L. Todoriko
Keywords
Related Articles
- EP ID EP213206
- DOI 10.22141/2312-413x.5.2.2017.105319
- Views 101
- Downloads 0
Significance of hepatitis B virus genotypes in clinical practice
Hepatitis B virus (HBV) infection remains a global public health problem with significant morbidity and mortality. During virus replication, numerous mutations are accumulated, and in the process of phylogenesis it leads...
Top of the most dangerous food parasites
The article gives a complete characterization of parasitic diseases, such as ascariasis and trypanosomiasis. According to the rating of the risk of food contamination by parasites, which was published by the World Health...
Selery medicinal plants in the Donbas
The performed studies determined the real number of species of medicinal plants in Apiaceae family growing on the Donbass territory. The study of literature and conducted field experiments revealed the presence of 41 spe...
Treatment and Diagnosis of Lambliasis in Modern Conditions
.
Efficiency of Genexpert MTB/RIF in Patients with Newly Diagnosed and Recurrent Pulmonary Tuberculosis
Genexpert MTB/RIF is an effective and feasible method for early diagnosis of tuberculosis. Using Genexpert MTB/RIF in combination with the culture technique on liquid medium in the automated microbiological system BACTEC...